Ask the Experts: Alzheimer’s fabrication controversy

A couple months ago, Science revealed that an Alzheimer’s research paper from 2006, detailing the toxicity of an amyloid fragment, may have contained fabricated images (read more about it here).    We asked Becky Carlyle (University of Oxford, UK), Mark Dallas (University of Reading, UK) and John Hardy (University College London, UK) to provide insight into what this allegation means for Alzheimer’s disease (AD) research, drug development, scientific publication and the public. Questions Where did you stand on the amyloid-beta hypothesis of Alzheimer's before this allegation was publicized? How did these revelations change your perception of the hypothesis? What does...